TW200302111A - Increased-dosage nelfinavir tablet and method of making same - Google Patents

Increased-dosage nelfinavir tablet and method of making same Download PDF

Info

Publication number
TW200302111A
TW200302111A TW092101739A TW92101739A TW200302111A TW 200302111 A TW200302111 A TW 200302111A TW 092101739 A TW092101739 A TW 092101739A TW 92101739 A TW92101739 A TW 92101739A TW 200302111 A TW200302111 A TW 200302111A
Authority
TW
Taiwan
Prior art keywords
patent application
item
mixture
nelfinavir
scope
Prior art date
Application number
TW092101739A
Other languages
English (en)
Chinese (zh)
Inventor
Grace Chen
James Leo Gallagher
Yosyong Surakitbanharn
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TW200302111A publication Critical patent/TW200302111A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)
TW092101739A 2002-01-28 2003-01-27 Increased-dosage nelfinavir tablet and method of making same TW200302111A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35142002P 2002-01-28 2002-01-28

Publications (1)

Publication Number Publication Date
TW200302111A true TW200302111A (en) 2003-08-01

Family

ID=27663002

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092101739A TW200302111A (en) 2002-01-28 2003-01-27 Increased-dosage nelfinavir tablet and method of making same

Country Status (23)

Country Link
EP (1) EP1469836A1 (fr)
JP (1) JP2005521661A (fr)
KR (1) KR20040079952A (fr)
CN (1) CN1713895A (fr)
AR (1) AR038236A1 (fr)
BR (1) BR0307190A (fr)
CA (1) CA2398226A1 (fr)
GT (1) GT200300016A (fr)
HN (1) HN2003000048A (fr)
HU (1) HUP0500512A2 (fr)
IL (1) IL162724A0 (fr)
MX (1) MXPA04007237A (fr)
NI (1) NI200300001A (fr)
NO (1) NO20043238L (fr)
NZ (1) NZ533283A (fr)
PA (1) PA8564301A1 (fr)
PE (1) PE20030730A1 (fr)
PL (1) PL373882A1 (fr)
RU (1) RU2004123206A (fr)
SV (1) SV2004001467A (fr)
TW (1) TW200302111A (fr)
WO (1) WO2003063837A1 (fr)
ZA (1) ZA200404367B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008053276A1 (fr) * 2006-10-30 2008-05-08 Collette Nv Pièce de transition pour le transfert de poudre ou de matière granulaire depuis une ouverture de déversement vers une chaîne de convoyage et procédé de transfert de poudre ou de matière granulaire
MX2010002438A (es) * 2007-09-03 2010-03-30 Lucent Technologies Inc Metodo y sistema para verificar automaticamente el estado de conectividad de un enlace de protocolo de internet en una red de protocolo de internet.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6499984B1 (en) * 2000-05-22 2002-12-31 Warner-Lambert Company Continuous production of pharmaceutical granulation
MXPA03009971A (es) * 2001-05-03 2004-02-12 Hoffmann La Roche FORMA DE DOSIFICACIoN FARMACEUTICA DE MESILATO DE NELFINAVIR AMORFO.

Also Published As

Publication number Publication date
NI200300001A (es) 2004-12-21
RU2004123206A (ru) 2005-04-20
PE20030730A1 (es) 2003-08-28
CN1713895A (zh) 2005-12-28
PA8564301A1 (es) 2003-09-05
SV2004001467A (es) 2004-05-07
HUP0500512A2 (hu) 2005-09-28
EP1469836A1 (fr) 2004-10-27
IL162724A0 (en) 2005-11-20
NO20043238L (no) 2004-08-02
BR0307190A (pt) 2004-11-03
ZA200404367B (en) 2006-05-31
NZ533283A (en) 2006-12-22
MXPA04007237A (es) 2004-10-29
KR20040079952A (ko) 2004-09-16
AR038236A1 (es) 2005-01-05
WO2003063837A1 (fr) 2003-08-07
PL373882A1 (en) 2005-09-19
JP2005521661A (ja) 2005-07-21
CA2398226A1 (fr) 2003-07-28
GT200300016A (es) 2003-09-11
HN2003000048A (es) 2003-10-28

Similar Documents

Publication Publication Date Title
EP0699436B2 (fr) Composition à libération contrôlée
TWI263507B (en) Cilostazol preparation
CN107875136B (zh) 一种阿莫西林药物制剂及其制备方法
CN1251990A (zh) 含有阿莫西林和克拉维酸盐的药物制剂
CN108785267B (zh) 一种缬沙坦氨氯地平片及其制备方法
CN106176640B (zh) 一种含枸橼酸托法替布的药物组合物及其制备方法
CN103877051B (zh) 一种依折麦布片的制备方法
CN104721156B (zh) 一种含利伐沙班的片剂
CN107582531A (zh) 一种利伐沙班固体制剂及其制备方法
WO2007018057A1 (fr) Comprime se desintegrant rapidement dans la cavite buccale et son procede de fabrication
CN102526748B (zh) 含有缬沙坦、氢氯噻嗪和苯磺酸氨氯地平的口服片剂
TW200302111A (en) Increased-dosage nelfinavir tablet and method of making same
CN107998097A (zh) 一种含奥美沙坦酯的片剂及其制备方法
CN108420798B (zh) 一种抗凝剂的速释药物制剂及其制备方法
CN110664771A (zh) 一种含盐酸培唑帕尼的药物组合物及其制备方法
CN1292743C (zh) 包衣的固体催眠制剂
EP1541161B1 (fr) Composition de comprime contentant un extrait issu de la medecine traditionnelle chinoise et procede de production de ce dernier
CN113244179B (zh) 一种稳定性好的碳酸镧片剂及其制备方法和其应用
CN1371276A (zh) 低剂量片剂及其制备方法
CN101653423A (zh) 拉西地平片及其制备方法
JP5941592B1 (ja) フィルムコーティングを施した着色固形製剤
WO2018050131A1 (fr) Procédé de production d'une formulation solide d'acétate d'abiratérone au moyen du procédé de granulation en lit fluide
Kulkarni et al. Design and development of Aceclofenac fast dissolvingtablets by different techniques
EP1494656B1 (fr) Composition orale analgesique avec liberation controlee d'un opioide
CN117482057A (zh) 一种稳定的盐酸格拉司琼片及其制备方法